Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 10/20 | 1.00 |
| ▸ | F3 | P13726 | 4/20 | 1.00 |
| ▸ | USP7 | Q93009 | 3/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.80 |
| ▸ | POLB | P06746 | 3/20 | 0.79 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.79 |
| ▸ | CES1 | P23141 | 3/20 | 0.79 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.79 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.79 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.79 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.79 |
| ▸ | PTPRC | P08575 | 2/20 | 0.79 |
| ▸ | PTPRF | P10586 | 2/20 | 0.79 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.79 |
| ▸ | ACP1 | P24666 | 2/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hederagenin SCHEMBL18818579 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL13395362 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL29523111 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL15382983 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL12968366 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL18704478 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL12919815 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL18293409 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL21892153 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA | |
| Hederagenin SCHEMBL14132125 | 1.00 | PTPN1 (1.00) | PTPN1F3USP7USP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2535 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617746-B2 | Method of preparing triterpenoid compound | NATIONAL TAIWAN UNIVERSITY (TW) | 2026-05-05 | — | — | US | claimed |
| CN-121574172-A | Hederagenin C-23 heterocyclic ester derivative, and preparation method and application thereof | 烟台大学 | 2026-02-27 | — | — | CN | claimed |
| CN-121569845-A | Application of saponin in inhibiting penicillium | 内蒙古清源保生物科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| US-20260053768-A1 | Sustained Nitric Oxide Releasing Drug Delivery Systems | HADAYA MAHER (US) | 2026-02-26 | — | — | US | claimed |
| EP-3731833-B1 | COMPOSITIONS CONTAINING THYMOHYDROQUINONE AND THEIR METHOD OF PREPARATION | SAMI SABINSA GROUP LTD (IN) | 2025-12-10 | — | — | EP | claimed |
| US-20250352445-A1 | COMPOSITIONS FOR SEBUM CONTROL | DYSON OPERATIONS PTE LTD (SG) | 2025-11-20 | — | — | US | claimed |
| WO-2025235336-A1 | SUSTAINED NITRIC OXIDE RELEASING DRUG DELIVERY SYSTEMS | HADAYA MAHER (US) | 2025-11-13 | — | — | WO | claimed |
| US-20250338841-A1 | Dry Powdered Compositions and Methods and Uses Thereof | NEOZYME INTERNATIONAL, INC. (US) | 2025-11-06 | — | — | US | claimed |
| WO-2025215232-A1 | A COMPOSITION COMPRISING A SAPONIN AND/OR AN ANTHELMINTIC AND/OR A MITOCHONDRIAL UNCOUPLER FOR THE TREATMENT OF LIVER DISEASE | RAINCASTLE BIO. LIMITED (GB) | 2025-10-16 | — | — | WO | claimed |
| US-20250295800-A1 | CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION | SAPREME TECH BV (NL) | 2025-09-25 | — | — | US | claimed |
| CN-1137748-A | Gas used as local and subcutaneous transmission carrier and microspheres filled with gas precursor | IMARX PHARMACEUTICAL CORP (US) | 1996-12-11 | — | — | CN | claimed |
| EP-0740528-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1996-11-06 | — | — | EP | claimed |
| WO-1995032006-A1 | GAS FILLED MICROSPHERES AS COMPUTED TOMOGRAPHY CONTRAST AGENTS | IMARX, PHARMACEUTICAL CORP. (US) | 1995-11-30 | — | — | WO | claimed |
| WO-1995024184-A1 | GAS FILLED MICROSPHERES AS MAGNETIC RESONANCE IMAGING CONTRAST AGENTS | UNGER EVAN C (US) | 1995-09-14 | — | — | WO | claimed |
| EP-0555484-B1 | WATER-SOLUBLE PENTACYCLIC TRITERPENE COMPOSITION AND PRODUCTION THEREOF | HOKKAIDOSUGAR CO LTD (JP) | 1995-09-06 | — | — | EP | claimed |
| WO-1995015118-A1 | GAS MICROSPHERES FOR TOPICAL AND SUBCUTANEOUS APPLICATION | IMARX PHARMACEUTICAL CORP. (US) | 1995-06-08 | — | — | WO | claimed |
| EP-0558509-B1 | USE OF MEDICAGO SAPONINS FOR THE PREPARATION OF COSMETIC OR PHARMACEUTICAL COMPOSITIONS, DERMATOLOGICAL COMPOSITIONS IN PARTICULAR, HELPING RENEW THE EPIDERMIS, STIMULATING REGROWTH OF HAIR, OR DELAYING HAIR LOSS | LVMH RECH (FR) | 1995-03-15 | — | — | EP | claimed |
| US-5314877-A | Water-soluble pentacyclic triterpene composition and method for producing the same | HOKKAIDO SUGAR CO., LTD. (JP) | 1994-05-24 | — | — | US | claimed |
| EP-0555484-A1 | WATER-SOLUBLE PENTACYCLIC TRITERPENE COMPOSITION AND PRODUCTION THEREOF | HOKKAIDOSUGAR CO., LTD. (JP) | 1993-08-18 | — | — | EP | claimed |
| US-4606911-A | PENTACYCLIC ACID TRITERPENES | ROHTO PHARMACEUTICAL CO. LTD. (JP) | 1986-08-19 | — | — | US | claimed |